< Back to latest news & events

Articles

Digital Health in 2023: Exploring Europe’s Patent Innovations

April 2024

The EPO recently published its 2023 Patent Index and there is, as seen in 2022, further increased patenting activity in key technologies relevant to the healthcare sector.

Spurred by the advent of transformative technologies including advances in AI capabilities and computing power, there is increased innovation in the fields of digital communications, medical technologies, and computer technology. For example, the rise of post-COVID solutions available in digital communications and therapeutics is evidence of the interest and potential for growth in this space.

It is not hard to see how computing technologies find applications in modern health solutions, such as remote patient monitoring and communication, AI-driven medical data analysis and diagnosis tools, robotic surgery, emerging specialised “techs” such as FemTech SexTech, AgeTech and Mental Health Tech and digital transformations in the health space.

Patent filings in 2023 reflect this surge in digital health innovation, with the European Patent Office (EPO) reporting an increase in applications related to digital health technologies. Digital communication filings have seen a huge 8.6% increase to 17,749 on top of an already significant 11.2% worldwide increase in 2022, positioning it as the leading area for patent filings. Medical technology filings have increased by 1.3% rise in 2023 to 15,985, while computer technology follows closely with a 1.2% increase to 15,746 filings in 2023. Biotechnology has also seen a 5.9% increase in filings to 8,367 in 2023.

These figures support my observations over the last year in terms of the range of technologies I have worked on in digital health, which are increasingly in areas of crossover of traditional disciplines (such as AI in biotechnology). I work increasingly with my colleagues in the life sciences, chemistry, and engineering groups, to fully dive into the technical details of a client’s innovation and work out a IP strategy suitable for their unique position.

As digital health technologies mature, the trajectory of these trends in the UK and Ireland is interesting. The number of both UK and Irish applicants filing applications at the EPO show a consistent increase in the fields of biotechnology and computer technology, with Ireland showing a marked steady increase in applications in medical technologies, perhaps reflective of the focus on innovation and support of the growing Irish MedTech scene.

Artificial Intelligence (AI) falls within the computer technologies category above, and is such a key technology right now that the EPO has specifically reported on this and how patent trends relate to the explosion of innovation in this area. The EPO reports  that there is, inevitably, a huge focus on developing and utilising AI technologies, with over 2000 European patents relating to artificial neural networks alone, with applications in digital health including image analysis (for example to identify suspected cancer), autonomous robots (with applications in robotic surgery) and speech recognition (for example as used in assistive and therapeutic technologies).

Overall, the future holds exciting prospects for innovations in digital health and the data shows that inventing activity in this field continues to flourish.

For inquiries regarding patenting within the digital health space and in crossover innovations in MedTech and digital health, our multidisciplinary teams at HGF are ready to assist. With expertise spanning many facets of MedTech and digital health technologies, our diverse team of attorneys across Europe, including specialists in the UK and Ireland, is ready to speak to you.


This article was written by Patent Director Janine Swarbrick 

Latest updates

Event - 11th - 12th May 2026

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe.

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe. It will be held on Monday 11-12th May …

Event details
Event - 27th April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Event details

Seven HGF Attorneys Recognised in the 2026 Pro Bono Recognition List

We’re proud to share that seven of our attorneys have been named on the 2026 Pro Bono Recognition List of England & Wales, recognising those who have dedicated 25 hours …

Read article

PRESS RELEASE - Oliver Pooley joins HGF as a Partner 21st April 2026

HGF is pleased to announce the appointment of Oliver Pooley who will be joining the firm as a Partner on 21st April 2026. Oliver joins our Technology & Engineering Group …

Read article
Event - 16th April 2026

MedTech Innovation Summit 2026

HGF Partner and Patent Attorney Adam Hines will be attending the MedTech Innovation Summit Dublin 2026, taking place from 28–30 April at The Shelbourne Hotel. As one of Europe’s premier …

Event details
Event - 2nd - 6th May 2026

INTA 2026 Annual Meeting

HGF’s European team are delighted to be attending the INTA Annual Meeting 2026, taking place from 2nd-6th May in London. As one of Europe’s leading IP firms, HGF brings together …

Event details
Event - 25th March 2026

HGF Women IP Inclusive Event

HGF are hosting Connected Bubbles Networking Event on Wednesday 25 March 2026 and this year they are teaming up with CIPA! In a profession built on collaboration, referrals and trusted …

Event details
Event - 16th, 17th March 2026

HGF are sponsors of IQPC Europe 2026

HGF is proud to sponsor IQPC’s Global IP Exchange Europe 2026, an exclusive invite-only forum bringing together senior in-house IP decision makers from across Europe. In a landscape shaped by …

Event details